Recommended for the vaccination of healthy dogs 9 weeks of age and older as an aid in the reduction of disease associated with
infection by borrelia burgdorferi. Is a liquid suspension of inactivated, purified outer surface protein (OspA) of borrelia
burgdorferi derived from a bacterial recombinant vector. Subcutaneous injection. 20 Doses.